In 2021, there were 1 140 new cases of thyroid cancer that accounted for 3.0% of all new cancer cases in Hong Kong. The crude annual incidence rate of cancer per 100 000 Hong Kong population was 15. Women have a higher chance of getting the cancer and the female to male ratio was about 4.2 to 1.
The development of thyroid cancer is slow and it may take a few years for the cancer cells to develop into an obvious mass. With current technology, doctors can detect thyroid cancer even when it is small and the new treatments can achieve a high cure rate. According to the Cancer Registry statistics, the five-year relative survival rates were very high (>95%) for stage I to III. Stage IV thyroid cancer still had a five-year survival rate of 69%. However, as the cancer develops slowly, there is still chance of recurrence within a number of years after the initial treatment. Therefore, regular follow-up is advised.
Thyroid is a gland in front of the neck beneath the voice box. It looks like a butterfly. It is an endocrine tissue which is responsible for the production of thyroxine. Situated behind the thyroid gland are parathyroid glands which secrete parathyroid hormone. Thyroxine is needed to keep the body functioning and its action affects blood sugar level, heart beat and kidney function. Parathyroid hormone helps regulate body calcium level. If cells in thyroid gland grow abnormally and they do not die as usual, cancer will be formed.
Thyroid cancer can be classified into 4 types:
Apart from these types of cancer, non-Hodgkin’s lymphoma can rarely occur in thyroid.
The exact cause of thyroid cancer in most patients is unknown. The following are risk factors that can increase the chance of developing thyroid cancer.
The commonly seen symptoms of thyroid cancer are the following:
Early thyroid cancer is not obvious and you may not be aware of its existence. To avoid delay in diagnosis and treatment, one should seek advice from a doctor when one worries about having a thyroid problem.
Currently, screening for thyroid cancer is not recommended for asymptomatic persons at average risk.
Persons at increased risk, including those with a history of head or neck irradiation in infancy or childhood, familial thyroid cancer or family history of multiple endocrine neoplasia type 2, should consider seeking advice from doctors regarding the need for and approach of screening.
Using a small needle, a sample of cells is taken out of a thyroid nodule and is examined under a microscope to check if there are cancer cells present. The doctor may use an ultrasound scanner to help guide the needle to the right area.
If a diagnosis can't be made after fine-needle aspiration, a doctor will make a small cut close to thyroid and extract a sample of tissue. The tissue will be examined under a microscope to check if there are cancer cells present.
Patients should provide information concerning the current medications used especially antiplatelet and anticoagulation drugs and any allergic history. In patients using anticoagulation and antiplatelet drugs, they may need to stop or modify the dosage of the medications.
The doctor makes use of ultrasound scanner to create a picture of the neck and the inside of the thyroid gland. Hence, one can learn if the nodules are solid or filled with fluid.
A small amount of radioactive iodine is injected into a vein in the arm. After 20 minutes, the patient will lie on the bed and a gamma camera will be positioned over patient’s neck to measure the radiation activity of the patient’s thyroid gland. Cancer cells do not absorb radioactive iodine as good as normal thyroid cells. Therefore, the image will show the position of the cancer.
Most people with thyroid cancer will have surgery. The surgeon removes the whole thyroid gland or part of it, depending on the patient's conditions. During the operation, surgeon will examine the lymph nodes close to the thyroid to see if they have been affected by cancer cells. If cancer has spread outside the gland, surgeon will remove the neighboring tissues as well.
After removal of entire or nearly all thyroid gland, patient needs to take thyroid hormone as replacement for the rest of his/her life. This also helps suppress the secretion of thyroid stimulating hormone (TSH). If the level of thyroid stimulating hormone is high, the remaining cancer cells may be stimulated, resulting in recurrence of cancer.
Should cancer cells still remain in the neck after the operation or the cancer cannot be removed by surgery, external radiation therapy is considered. This type of treatment is more commonly used in patients suffering from medullary thyroid cancer or anaplastic thyroid cancer. Another indication for this therapy is recurrence of cancer in the neck.
Prior to the therapy, a transparent mask which fits the patient's head and neck is prepared. This mask helps immobilize the head during the therapy.
After removal of the thyroid gland, patient may experience the following side effects:
Potential risk and complications of surgical treatment for thyroid cancer includes:
After surgery, patient should try to get out of the bed at the earliest possible time. If patient needs to stay in bed, patient should follow medical staff's instructions to maintain sufficient movement and to take deep breaths. For a better airway, patient should be in a recumbent position when lying on bed. Patient may feel pain on swallowing and patient may take fluid or soft food.
Take medications (e.g. thyroxine hormone, calcium and vitamin D) according to doctor’s instructions.
Even though the thyroid gland has been removed, there is still chance of recurrence. Therefore, regular follow-up is vital in the early detection of cancer recurrence. Half a year after radioactive iodine therapy, a whole body scan may be done to see if cancer cells remain in the body. Thereafter, regular body checkup and blood test for thyroglobulin level will be done.
Because of the side effects of the therapy, a patient may not tolerate normal diet and patient can replace meals with nutritious, high-calorie drinks.
Radioactive iodine is a form of iodine that emits radiation. When it is absorbed by the body, it will be concentrated in thyroid tissue. The radiation given off will destroy any remaining thyroid cells that may have escaped surgical removal. This reduces the risk of tumour recurrence and facilitates detection of early relapse by blood tests. It can also be used to treat cancer that has returned and still achieve a cure.
Radioactive iodine is taken by mouth in liquid or pill form. Most of the radioactivity is absorbed by thyroid tissue. Any radioactivity not collected by thyroid tissue will be eliminated within a few days through urine, faeces, saliva and sweat. Other organs in the body will receive some incidental radiation during this time, but this small amount of radiation typically does not produce any adverse effect.
The following preparation ensures good absorption of radioactive iodine. Please refer to the instruction sheet given for the exact dates.
For further information please contact your doctor.